Skip to main content

Advertisement

Log in

Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigate the efficacy and safety of combined common femoral artery (CFA) endarterectomy with superficial femoral artery (SFA) stenting plus Shuxuening Injection (舒血宁注射液) infusion in patients with complex multifocal arterial steno-obstructive lesions of the lower extremities.

Methods

From March 2006 to March 2011, 104 lower limbs in 96 patients with multilevel peripheral arterial steno-occlusive disease, involving SFA as well as CFA and deep femoral artery (DFA) orifice, were treated by combined surgical with endovascular therapy, such as SFA stenting as an adjunct to CFA endarterectomy and patch angioplasty with the great saphenous vein. Before the end of the operation, 20 mL of Shuxuening Injection was infused through the catheter located in the treated artery. Technical and hemodynamic success, as well as primary and primary-assisted patency, was determined according to the Society for Vascular Surgery Guidelines. During follow-up, clinical status assessment, ankle-brachial index (ABI) test, and duplex Doppler ultrasound were administered every 6 months, and computed tomography angiography or magnetic resonance angiography was performed at 12, 24, and 36 months after discharge.

Results

All patients underwent successful combined CFA endarterectomy with SFA stenting treatment. The average ABI after the combination treatment increased from pretreatment of 0.32±0.21 to 0.82±0.24 (P<0.01). No perioperative death and major limb amputations occurred. The mean duration of follow-up for 104 limbs from 96 patients was 1,180 days (range, 196–2,064 days). During follow-up, 5 patients died due to myocardial infarction, cerebral infarction, or pneumonia, and 5 patients were lost to follow-up. There were 21 cases (21.4%) of restenosis, with 15 that occurred in-stent and 6 near the distal end of the stent. A total of 18 (18.3%) reinterventions were performed, including 6 balloon angioplasty, 8 restenting procedures, 2 bypass surgeries, and 2 major limb amputations. The primary patency rates were 92.2%, 76.8%, and 61.3% at 12, 24, and 36 months, respectively, while the primary-assisted patency rates were 94.4%, 83.2%, and 75.6% at 12, 24, and 36 months, respectively.

Conclusion

The combined CFA endarterectomy with SFA stenting plus Shuxuening Injection infusion appears to offer a safe, less invasive, and effective treatment option to patients with chronic lower extremity ischemia due to complex multifocal peripheral artery disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Andrews RT, Venbrux AC, Magee CA, Bova DA. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radio 1999;10:1219–1228.

    Article  CAS  Google Scholar 

  2. Ballard JL, Sparks SR, Taylor FC, Bergan JJ, Smith DC, Bunt TJ, et al. Complications of iliac artery stent deployment. J Vasc Surg 1996;24:545–555.

    Article  PubMed  CAS  Google Scholar 

  3. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular disease. Cardiovasc Drug Rev 2004;22:309–319.

    Article  PubMed  CAS  Google Scholar 

  4. Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992;34:352–358

    PubMed  CAS  Google Scholar 

  5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. J Vasc Surg 2007;45(Suppl):S5–67.

    Article  PubMed  Google Scholar 

  6. Cotroneo AR, Jezzi R, Marano G, Fonio P, Nessi F, Gandini G, et al. Hybrid therapy in patients with complex peripheral multifocal steno-obstructive vascular disease: two-year results. Cardiovasc Interv Radio 2007;30:355–361.

    Article  Google Scholar 

  7. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New Engl J Med 2006;354:1879–1888.

    Article  PubMed  CAS  Google Scholar 

  8. Mewissen MW. Sel f -expanding ni t inol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radio 2004;7:2–5.

    Article  Google Scholar 

  9. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516–521.

    Article  PubMed  Google Scholar 

  10. Nishibe T, Kondo Y, Nishibe M, Muto A, Dardik A, Nishibe T. Stent placement of femoropopliteal arterial occlusive disease in high-risk patients: preliminary results. Surg Today 2009;39:21–26.

    Article  PubMed  Google Scholar 

  11. Myers KA. Reporting standards and statistics for evaluating intervention. Cardiovasc Surg 1995;3:455–461.

    Article  PubMed  CAS  Google Scholar 

  12. Ballotta E, Gruppo M, Mazzalai F, Da Giau G. Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery 2010;147:268–274.

    Article  PubMed  Google Scholar 

  13. Nelson PR, Powell RJ, Schermerhorn ML, Fillinger MF, Zwolak RM, Walsh DB, et al. Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg 2002;35:1107–1113.

    Article  PubMed  Google Scholar 

  14. Mousa A, Abdel-Hamid M, Ewida A, Saad M, Sahrabi A. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic extremity ischemia: preliminary result. Intern Soc Vasc Surg 2010;18:71–76.

    Google Scholar 

  15. Edwards WH Jr, Martin RS III, Jenkins JM, Edwards WH Sr, Mulherin JL Jr. Primary graft infections. J Vasc Surg 1987;6:235–239.

    PubMed  Google Scholar 

  16. Pons VG, Wurtz R. Vascular graft infections: a 25-year experience of 170 cases. J Vasc Surg 1991;13:751–753.

    Article  PubMed  CAS  Google Scholar 

  17. Kemmel RM, Murphy RX, Chowdary RP. Optimal management of inguinal vascular graft infections. Ann Plast Surg 1994;32:623–629.

    Article  Google Scholar 

  18. Spence MT, David AW, Eugene ML, Jonathan SL. Outcomes in the management of vascular prosthetic graft infections confined to groin: a reappraisal. Ann Vasc Surg 1996;10:117–122.

    Article  Google Scholar 

  19. Bao YM, Liu AH, Zhang ZX, Li Y, Wang XY. Effects of Ginkgo biloba extract 50 preconditioning on contents of inflammation-related cytokines in myocardium of rats with ischemia-reperfusion injury. J Chin Integr Med (Chin) 2010;8:373–378.

    Article  Google Scholar 

  20. Yuan LP, Chen ZW, Li F, Dong LY, Chen FH. Protective effect of total flavones of rhododendra on ischemic myocardial injury in rabbits. Am J Chin Med 2006;34:483–492.

    Article  PubMed  CAS  Google Scholar 

  21. Saleem S, Zhuang H, Biswal S, Christen Y, Dore S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008;12:3389–3396.

    Article  Google Scholar 

  22. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000;108:276–281.

    Article  PubMed  CAS  Google Scholar 

  23. Peters H, Kieser M, Holscher U. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication-a placebo-controlled, double-blind multicenter trial. Vasa 1998;27:106–110.

    PubMed  CAS  Google Scholar 

  24. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357–362.

    Article  PubMed  CAS  Google Scholar 

  25. Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting. J Vasc Surg 2010;52:232–236.

    Article  PubMed  Google Scholar 

  26. Reed AB. Endovascular as an open adjunct: use of hybrid endovascular treatment in the SFA. Semin Vasc Surg 2008;21:200–203.

    Article  PubMed  Google Scholar 

  27. Sikkink CI, Reijnen MM, Zeebregts CI. The creation of the optimal dedicated endovascular suite. Eur J Endovasc Surg 2008;35:198–204.

    Article  CAS  Google Scholar 

  28. Ebaugh JL, Gagnon D, Owens CD, Conte MS, Raffeto JD. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. Am J Surg 2008;196:634–640.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tian-you Wang  (王天佑).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng, H., Chen, Xm., Li, Cy. et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results. Chin. J. Integr. Med. 18, 417–422 (2012). https://doi.org/10.1007/s11655-012-1113-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-1113-z

Keywords

Navigation